Tetrabenazine is a medication that treats involuntary movements caused by Huntington’s disease.
This condition attacks your brain, causing unsteady and uncontrollable movements (chorea) in your hands, feet and face.
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the U.S. Food and Drug Administration approved the use of tetrabenazine to treat chorea associated with Huntington's disease. Although other drugs had been used "off label," tetrabenazine was the first approved treatment for Huntington's disease in the U.S. The compound has been known since the 1950s.
Origin
Made in, and imported from Iran
Brand
Active Substance
TetrabenazineUses